Rocklatan Solution/ Drops
Product Images NDC 70727-529

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocklatan (NDC 70727-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alcon Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Netarsudil Mesylate (Image 01)

Chemical structure diagram of the active ingredient netarsudil, including its molecular components and associated sulfonic acid groups as depicted in the image.*

FDA Label Image

The Chemical Structure Of Latanoprost (Image 02)

Chemical structure of netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% active ingredients, showing a detailed molecular diagram with various bonds and functional groups.*

FDA Label Image

Figure 1 (Image 03)

A line graph comparing the intraocular pressure measurements over time in patients treated with Rocklatan, Netarsudil, and Latanoprost. The x-axis shows time points at day 15, day 43, and day 90, each with three measurement times (8 AM, 10 AM, and 4 PM). The y-axis represents pressure values ranging from 14 to 23 mmHg. Rocklatan shows consistently lower pressure values than either Netarsudil or Latanoprost alone throughout the study period.*

FDA Label Image

Figure 2 (Image 04)

A line graph comparing intraocular pressure (IOP) measurements at three time points (8AM, 10AM, 4PM) on Days 15, 43, and 90 for Rocklatan, netarsudil, and latanoprost. Data points show Rocklatan consistently having the lowest IOP values, followed by latanoprost, then netarsudil. The graph includes baseline IOP values before treatment initiation for each medication.*

FDA Label Image

Rocklatan (netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Carton Label (Image 05)

Packaging label for Rocklatan ophthalmic solution 0.02%/0.005%, a sterile topical eye drop solution. The label shows the proprietary and generic names, volume of 2.5 mL, and states it is Rx only. It includes manufacturer information for Aerie Pharmaceuticals, Inc., barcode, usage instructions, preservative, inactive ingredients, and storage conditions.*

FDA Label Image

Rocklatan (netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Sample Carton Label (Image 06)

Rocklatan 0.02%/0.005% ophthalmic solution carton label featuring netarsudil and latanoprost. The 2.5 mL sterile drops are for topical eye application, labeled as Rx only and sample not for resale. Manufactured for Aerie Pharmaceuticals by Alcon Laboratories, Inc., the label includes dosage instructions, storage conditions, and preservative information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.